# Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected Persons

> **NCT01026454** · PHASE4 · COMPLETED · sponsor: **University of Washington** · enrollment: 32 (actual)

## Conditions studied

- HSV Infection
- HIV Infection

## Interventions

- **DRUG:** acyclovir
- **DRUG:** valacyclovir

## Key facts

- **NCT ID:** NCT01026454
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-11
- **Final completion:** 2010-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2014-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01026454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01026454, "Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected Persons". Retrieved via AI Analytics 2026-06-21 from https://api.ai-analytics.org/clinical/NCT01026454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*